Balanced news tone
News Sentiment
DNA sentiment intelligence
Ginkgo Bioworks Holdings, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
79/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +13.3% over four weeks, trend inactive, and below fair value.
Ginkgo Bioworks (NYSE: DNA) CFO logs RSU vesting and tax sell-to-cover
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Ginkgo Bioworks (NYSE: DNA) CFO logs RSU vesting and tax sell-to-cover
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2026 21:12
- Source
- Stock Titan
Ginkgo Bioworks (NYSE: DNA) insider Steve Coen plans Class A stock sale
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 20:43
- Source
- Stock Titan
Ginkgo Bioworks Holdings' Stock Sinks To US$9.07, But Insiders Sold Even Lower
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 09 Jul 2026 07:00
- Source
- simplywall.st
Ginkgo Bioworks (DNA) director Henry Christian O receives 25,000 RSU equity grant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Ginkgo Bioworks: Another Lost Year (NYSE:DNA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Seeking Alpha
How The Ginkgo Bioworks (DNA) Story Is Shifting After The Biosecurity Divestiture And Target Cut
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 11 May 2026 07:00
- Source
- Market source
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- PR Newswire
Ginkgo Bioworks reports Q1 revenue decline, reaffirms cash burn
- Tone
- Negative 34/100
- Event
- Balance sheet
- Published
- 07 May 2026 07:00
- Source
- Investing.com
Will Ginkgo Bioworks Holdings (NYSE:DNA) Spend Its Cash Wisely?
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 30 Apr 2026 07:00
- Source
- simplywall.st
Ginkgo Bioworks will take investor questions after May 7 results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Stock Titan
Ginkgo Bioworks CFO Coen sells $212k in shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Investing.com
A Look At Ginkgo Bioworks (DNA) Valuation After Earnings Update And Invaio Collaboration
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Mar 2026 08:00
- Source
- Market source
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Feb 2026 08:00
- Source
- PR Newswire
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Feb 2026 08:00
- Source
- Market source
Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Market source
Ginkgo Bioworks enacts reverse stock split, amends charter
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Aug 2024 07:00
- Source
- Investing.com
Ginkgo Bioworks Provides Compensation Information Related to Recent Acquisitions
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 28 Feb 2024 08:00
- Source
- PR Newswire